Pharmesis International Ltd. (SGX:BFK)

Singapore flag Singapore · Delayed Price · Currency is SGD
0.4350
0.00 (0.00%)
At close: Oct 10, 2025
Market Cap13.79M
Revenue (ttm)12.62M
Net Income (ttm)1.85M
Shares Out31.70M
EPS (ttm)0.06
PE Ratio7.47
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume5,620
Open0.4350
Previous Close0.4350
Day's Range0.4350 - 0.4350
52-Week Range0.1430 - 0.7000
Beta-0.95
RSI41.17
Earnings DateNov 10, 2025

About Pharmesis International

Pharmesis International Ltd., an investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China. The company provides prescribed products and over-the-counter drugs. It offers western medicine products under the Kinna brand, including Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Compound Procaine hydrochloride to treat arterioscler... [Read more]

Industry Pharmaceutical Preparations
Founded 1996
Employees 1,096
Stock Exchange Singapore Exchange
Ticker Symbol BFK
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.